nomifensine has been researched along with Binge Eating in 3 studies
Nomifensine: An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p266)
nomifensine : An N-methylated tetrahydroisoquinoline carrying phenyl and amino substituents at positions C-4 and C-8, respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gelenberg, AJ | 1 |
| Hudson, JI | 1 |
| Pope, HG | 1 |
| Price, WA | 1 |
| Babai, MR | 1 |
1 trial available for nomifensine and Binge Eating
| Article | Year |
|---|---|
Antidepressant drug therapy for bulimia: current status revisited.
Topics: Bulimia; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; N | 1987 |
2 other studies available for nomifensine and Binge Eating
| Article | Year |
|---|---|
Imperfect drugs in an imperfect world.
Topics: Bulimia; Bupropion; Clinical Trials as Topic; Clozapine; Depressive Disorder; Humans; Nomifensine; P | 1992 |
Newer antidepressants in the treatment of bulimia nervosa.
Topics: Antidepressive Agents; Bulimia; Bupropion; Humans; Lithium; Lithium Carbonate; Nomifensine; Propioph | 1987 |